Bio Electrolyte Liquid
NDC Package 43857-0567-1
Package Information
Bio Electrolyte (boron citrate, calcium gluconate, chromium picolinate, cobalt gluconate, copper gluconate, magnesium gluconicum dihydricum, manganese gluconate, nickel acetate, potassium gluconate, selenium dioxide, sodium gluconate, zincum gluconicum, ferrum sulphuricum, kali phosphoricum, vanadium metallicum, calcarea phosphorica) liquids is to speed recovery time after extreme exertion. This formulation utilizes a liquid delivery system. Marketed by Bioactive Nutritional, Inc., this product is identified by NDC 43857-0567.
Identification & Billing
Clinical Specifications
- BORON CITRATE 6 [hp_X]/mL
- CALCIUM GLUCONATE 6 [hp_X]/mL
- CHROMIUM PICOLINATE 6 [hp_X]/mL
- COBALTOUS GLUCONATE 6 [hp_X]/mL
- COPPER GLUCONATE 6 [hp_X]/mL
- DIBASIC POTASSIUM PHOSPHATE 8 [hp_X]/mL
- FERROUS SULFATE 8 [hp_X]/mL
- MAGNESIUM GLUCONATE 6 [hp_X]/mL
- MANGANESE GLUCONATE 6 [hp_X]/mL
- NICKEL ACETATE 6 [hp_X]/mL
- POTASSIUM GLUCONATE 6 [hp_X]/mL
- SELENIUM DIOXIDE 6 [hp_X]/mL
- SODIUM GLUCONATE 6 [hp_X]/mL
- TRIBASIC CALCIUM PHOSPHATE 9 [hp_X]/mL
- VANADIUM 8 [hp_X]/mL
- ZINC GLUCONATE 6 [hp_X]/mL
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Copper Absorption Inhibitor - [EPC] (Established Pharmacologic Class)
- Decreased Copper Ion Absorption - [PE] (Physiologic Effect)
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Magnetic Resonance Contrast Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Paramagnetic Contrast Agent - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 43857 - Bioactive Nutritional, Inc.
- 43857-0567 - Bio Electrolyte
- 43857-0567-1 - 60 mL in 1 BOTTLE, DROPPER
- 43857-0567 - Bio Electrolyte
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43857-0567-1 identifies a specific commercial package of 60 ml in 1 bottle, dropper of Bio Electrolyte, a human over the counter drug labeled by Bioactive Nutritional, Inc.. This liquid is formulated for oral use and contains boron citrate; calcium gluconate; chromium picolinate; cobaltous gluconate; copper gluconate; dibasic potassium phosphate; ferrous sulfate; magnesium gluconate; manganese gluconate; nickel acetate; potassium gluconate; selenium dioxide; sodium gluconate; tribasic calcium phosphate; vanadium; zinc gluconate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bioactive Nutritional, Inc. on December 28, 2020. The current certification is valid through December 31, 2026.
How is this Bioactive Nutritional, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43857056701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.